) Kaposi sarcoma associated herpesvirus (KSVH or HHV-8) is the probable causative etiological agent of all forms of KS. Unlike most herpesviruses, infection with KSHV is very rare in most human populations except in Central Africa and the Mediterranean, but it is very common in male homosexual AIDS patients, who also have high rates of KS lesions. The genomes are found in most or all KS spindle and endothelial cells, as well as in Primary Effusion Lymphoma and Multicentric Castleman's Disease tumor cells in AIDS patients. Only the viral nuclear proteins LANA and vCYCD are known to be expressed in all HHV-8 associated tumor cells in vivo, but the hypervariable ORF-K1 and ORF-K15 membrane proteins that we have found to be encoded at the extreme LHS and RHS ends of the genome are also candidate oncogenes or latency regulators. We have identified four distinct subtypes of the Ig receptor-like ORF-K1 protein and two very different forms (or alleles ) of the complex spliced ORF-K15 gene. ORF-K1 is a highly glycosylated membrane signaling protein, that produces transformed foci in DNA-transfected cells and substitutes for the STP oncogene in HVS tumorigene- sis assays. ORF-K15 is a highly diverged orthologue of the EBV LMP2 gene and appears to encode a latent state integral membrane signaling protein. In this project we plan to (1) Determine the patterns of expression of ORF-K15 mRNA and protein in KS lesions and PEL tumor cells; (2) Ask whether there are distinctive or alternative latent and lytic promoter pathways for ORF-K15 P and M gene regulation; (3) Evaluate the functional activity of the two conserved YXXL motifs in the ORF-K15 cytoplasmic tail in lymphoid cell signaling assays and phosphotyrosine kinase interactions; (4) Determine whether Tet-inducible intact ORF-K15 alters cell growth or proliferation in focus forming assays and whether it blocks B cell activation or signaling and EBV or HHV8 reactivation, and (5) Initiate long-term genetic studies to generate ORF-K15 deleted HHV8 for directly assessing its role in latency and transformation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA081400-03
Application #
6609118
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2002-07-10
Project End
2003-06-30
Budget Start
Budget End
Support Year
3
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Beachler, Daniel C; Gellert, Lan L; Jacobson, Lisa P et al. (2011) Kaposi sarcoma-associated herpesvirus serum DNA and antibodies not associated with subsequent non-Hodgkin lymphoma risk. J Acquir Immune Defic Syndr 56:188-92
Lechowicz, Maryjo; Dittmer, Dirk P; Lee, Jeannette Y et al. (2009) Molecular and clinical assessment in the treatment of AIDS Kaposi sarcoma with valproic Acid. Clin Infect Dis 49:1946-9
Fu, De-Xue; Tanhehco, Yvette; Chen, Jianmeng et al. (2008) Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors. Nat Med 14:1118-22
Hayward, G S; Zong, J C (2007) Modern evolutionary history of the human KSHV genome. Curr Top Microbiol Immunol 312:1-42
Zong, Jian-Chao; Arav-Boger, Ravit; Alcendor, Donald J et al. (2007) Reflections on the interpretation of heterogeneity and strain differences based on very limited PCR sequence data from Kaposi's sarcoma-associated herpesvirus genomes. J Clin Virol 40:1-8
Zong, Jian-Chao; Kajumbula, Henry; Boto, William et al. (2007) Evaluation of global clustering patterns and strain variation over an extended ORF26 gene locus from Kaposi's sarcoma herpesvirus. J Clin Virol 40:19-25
Yu, Yanxing; Wang, Shizhen Emily; Hayward, Gary S (2005) The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation. Immunity 22:59-70
Lubyova, Barbora; Kellum, Merrill J; Frisancho, Augusto J et al. (2004) Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 stimulates the transcriptional activity of cellular IRF-3 and IRF-7. J Biol Chem 279:7643-54
Wang, Shizhen Emily; Wu, Frederick Y; Chen, Honglin et al. (2004) Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway. J Virol 78:4248-67
Guo, Hong-Guang; Sadowska, Mariola; Reid, William et al. (2003) Kaposi's sarcoma-like tumors in a human herpesvirus 8 ORF74 transgenic mouse. J Virol 77:2631-9

Showing the most recent 10 out of 15 publications